Phase 4 Master Protocol for Patients Prescribed Prademagene Zamikeracel for the Treatment of Wounds

NCT07717736 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Epidermolysis Bullosa (EB)
Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Dystrophic Epidermolysis Bullosa (DEB)

Interventions

BIOLOGICAL: Non-conforming pz-cel surgical application to RDEB wounds
PROCEDURE: Additional biopsies
BIOLOGICAL: Pz-cel surgical application to DEB wounds

Sponsor

Abeona Therapeutics, Inc